Mark Melillo
@markmelillo
Husband, Father, Investor
ID: 528358862
18-03-2012 09:59:15
314 Tweet
61 Takipçi
526 Takip Edilen
There is a dire need for #breastcancer assessment software, and Volpara Health (#ASX: $VHT) is filling the gap. The #AI #biotech company has signed five new contracts worth $11.34m with major US healthcare companies, as well as a contract renewal worth $1.3m. thesentiment.com.au/volpara-signs-…
Onsite Women's Health is a leading provider in OBGYN primary care and mammography nationwide. Both Volpara Health & Onsite are committed to ensuring patients have convenient access to high quality care. onsitewomenshealth.com/press-release/…
Machine learning and AI are changing mammography screening, making it more effective than ever. Recent U.S. studies found that Volpara Health TruDensity and ScreenPoint Medical Transpara can predict long-term risk of advanced and interval breast cancers. bit.ly/3WUnubW